Clinical Trial Update: The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating the anti-anginal effects of N-acetylcysteine in patients with angina and non-obstructive coronary arteries (ANOCA). …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Non-obstructive Coronary Artery Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Adelaide | Conditions: Angina Attacks, Non Obstructive Coronary Artery Disease | Phase 2 | Status: NOT_YET_RECRUITING